Dong Xi-Feng, Yue Lan-Zhu, Fu Rong, Shao Zong-Hong
Clin Lab. 2014;60(3):495-9. doi: 10.7754/clin.lab.2013.130339.
A case with 17-year detailed illness history including evolution of polycythemia vera (PV) to myelofibrosis (MF) and then biphenotype acute leukemia (BAL) was reported. Ten years of PV followed by seven years of MF and then BAL, the patient experienced a classical "complete course" of myeloproliferative neoplasm (MPN). High WBC counts as well as low Hb and platelet counts in MF phase, long disease course, older than 50 years age, and positive JAK2 were her high risk factors of transformation from MPN to leukemia. Pancytopenia in her secondary MF phase responded well to the therapy of corticosteroids, which indicated that the immune mechanism was involved in the pathogenesis of MF. Progression of PV to MF and then BAL might be related to discontinuation of interferon-alpha because of poor tolerance.
报告了一例有17年详细病史的病例,包括真性红细胞增多症(PV)演变为骨髓纤维化(MF),进而发展为双表型急性白血病(BAL)。患者先有10年的PV,接着是7年的MF,然后是BAL,经历了骨髓增殖性肿瘤(MPN)的典型“完整病程”。MF阶段白细胞计数高以及血红蛋白和血小板计数低、病程长、年龄大于50岁和JAK2阳性是她从MPN转化为白血病的高风险因素。她继发性MF阶段的全血细胞减少对皮质类固醇治疗反应良好,这表明免疫机制参与了MF的发病机制。PV进展为MF进而发展为BAL可能与因耐受性差而停用干扰素-α有关。